Tag: Data integrity

Addressing Weak System Access Controls During Inspections to Ensure 21 CFR Part 11 Compliance Pharmaceutical manufacturing facilities are under constant scrutiny to maintain compliance with regulations governing electronic records and…

Addressing Misuse of Electronic Signatures in Compliance Audits: A Comprehensive Playbook In today’s highly regulated pharmaceutical landscape, the efficacy of electronic signatures during compliance audits is critical. Misuse of electronic…

Managing Record Retention Failures During Operational Systems: A Strategic Playbook Failures in record retention during system operations can disrupt processes, hinder compliance, and potentially lead to regulatory sanctions. For pharmaceutical…

Addressing Record Retention Failures During System Upgrades: An Inspection-Ready Playbook In the pharmaceutical industry, system upgrades are a critical part of maintaining compliance and operational efficiency. However, these transitions can…

Addressing the Misuse of Electronic Signatures During Compliance Audits: A Practical Playbook In the dynamic landscape of pharmaceutical manufacturing and quality compliance, the misuse of electronic signatures during audits poses…

Addressing Record Retention Failures During System Upgrades to Prevent Part 11 Findings In the ever-evolving landscape of pharmaceutical manufacturing, system upgrades can inadvertently lead to record retention failures, posing significant…

Addressing Record Retention Issues During the Validation Lifecycle to Prevent Part 11 Findings Record retention failures represent a critical threat in pharmaceutical manufacturing, particularly during the validation lifecycle of Electronic…

Strategies for Managing Uncontrolled Hybrid Paper-Electronic Workflows During Compliance Audits In the evolving landscape of pharmaceutical manufacturing, the integration of hybrid paper-electronic workflows has become a common practice. While these…

Addressing Electronic Signature Misuse Throughout the Validation Lifecycle In pharmaceutical manufacturing and quality control, the implementation of electronic signatures holds significant potential for operational efficiency and compliance. However, misuse of…

Addressing Uncontrolled Hybrid Paper-Electronic Workflows in Validation Lifecycle In today’s pharmaceutical landscape, hybrid paper-electronic workflows present significant challenges, particularly in maintaining compliance during the validation lifecycle. As organizations strive for…

Addressing Weaknesses in System Access Controls During the Validation Lifecycle In the fast-paced pharmaceutical environment, compliance with 21 CFR Part 11 is critical. However, weaknesses in system access controls can…

A Comprehensive Playbook for Addressing Record Retention Failures in Pharmaceutical Systems Record retention failures pose significant challenges during system operation, especially in relation to compliance with 21 CFR Part 11.…